Discovery can lead to new antiviral treatments against Crimean-Congo hemorrhagic fever

By | April 19, 2022
Researchers at Karolinska Institutet in Sweden have identified key signaling pathways that when blocked by existing drug candidates limit reproduction of the Crimean-Congo hemorrhagic fever (CCHF) virus.